The largest database of trusted experimental protocols

19 protocols using avibactam

1

Ceftazidime/Avibactam Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceftazidime/avibactam MIC were tested by broth microdilution according to CLSI guideline (M100, 28th Edition, 2018) using a fixed concentration of avibactam (MedChemExpress. New Jersey. USA) 4 μg/ml. Each isolate was tested in duplicate; a third replicate was necessary if there was disagreement between the first two broth microdilution results. For Kirby-Bauer method, plates were incubated at 35 °C and read after 16–20 h incubation, ceftazidime (30 μg) disk containing different avibactam content (0 μg, 10 μg, 25 μg, 50 μg) were used for disk diffusion test, k diffusion tests were performed in triplicate in parallel with broth microdilution, the mean value of the three inhibition zone diameter is used for statistical analysis. Escherichia coli ATCC 25922 and Escherichia coli ATCC 32518 were used for quality control. Isolates were considered to be susceptible to CAZ/AVI when MICs were ≤ 8/4 mg/L (CLSI, M100, 28th Edition, 2018).
+ Open protocol
+ Expand
2

Antimicrobial agents for in vivo studies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available cefiderocol (Shionogi, Japan), ceftazidime (Sandoz, IL, USA; Astral Steri Tech Pvt Ltd, India), ampicillin/sulbactam (Meitheal Pharmaceuticals, IL, USA) and meropenem (Aurobindo Pharma Limited-Hyderabad, India) were used for all in vivo experiments. Analytical grade avibactam (MedChemExpress, NJ, USA) was used in the ceftazidime/avibactam human simulating regimen (HSR).16 (link) Analytical standard powders were used for the preparation of broth microdilution MIC trays (Cefiderocol: Shionogi, Japan; ceftazidime: MedChemExpress, NJ, USA; avibactam: MedChemExpress, NJ, USA; meropenem: Sigma-Aldrich, WY, USA; ampicillin: MedChemExpress, NJ, USA; sulbactam: United States Pharmacopeial Convention, MD, USA).
+ Open protocol
+ Expand
3

Antimicrobial Susceptibility Testing of E. coli and K. pneumoniae

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial susceptibility testing was performed and interpreted according to the Clinical and Laboratory Standards Institute (CLSI) guidelines and breakpoints (M100, 31st edition) by the agar dilution method. E. coli ATCC 25922 and K. pneumoniae ATCC 700603 served as control strains.
The antibiotics we used included meropenem (Hanhui Pharmaceutical Co., Ltd., China), imipenem (Merck Sharp & Dohme Corp., USA), cefepime (Jiangsu Hengrui Pharmaceutical Co., Ltd., China), piperacillin (Suzhou Erye Pharmaceutical Co., Ltd., China), ceftazidime (Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., China), tazobactam (Meilunbio, China), avibactam (MedChemExpress, USA), aztreonam (Sigma-Aldrich, USA), amikacin (Meilunbio), cefuroxime (Esseti Farmaceutici S.r.l., Italy), fosfomycin (Harbin Pharmaceutical Group Co., Ltd. China), levofloxacin (Daiichi Sankyo Company Limited, Beijing, China), and cefotaxime (North China Pharmaceutical Hebei Huamin Pharmaceutical Co., Ltd., China).
+ Open protocol
+ Expand
4

Engineered KPC Variants in Klebsiella

Check if the same lab product or an alternative is used in the 5 most similar protocols
The pUBYT vector containing blaKPC-3 under the ISKpn7 promoter was used as a template for site-directed mutagenesis to create pUBYT containing blaKPC-2 and blaKPC-4 with the same promoter (45 (link)). The single point mutation in KPC-2 (Y274H) and double point mutations in KPC-4 (P104R, V240G) were introduced using a QuikChange Lightning site-directed mutagenesis kit (Agilent Genomics) with the primers specified in Table S1 in the supplemental material. Klebsiella pneumoniae Ecl8 was transformed with the resulting pUBYT constructs via electroporation.
S. maltophilia K279a is a well-characterized isolate from Bristol, United Kingdom, and was obtained as previously reported (46 (link)).
MIC values were determined using broth microdilution, in triplicate, in cation-adjusted Mueller-Hinton broth (Sigma) according to the Clinical and Laboratory Standards Institute (CLSI) guidelines (47 ). Experiments were performed in microtiter plates (Corning) containing medium with ceftazidime, imipenem, or aztreonam with inhibitor (4 mg liter−1 avibactam [MedChemExpress] or relebactam [MedChemExpress] dissolved in dimethyl sulfoxide). Plates were incubated overnight at 37°C for 18 to 24 h, and the absorbance at 600 nm was read using a POLARstar Omega (BMG LabTech) plate reader.
+ Open protocol
+ Expand
5

Multi-drug Resistant Pseudomonas Isolates Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifteen XDRPA isolates, defined as nonsusceptibility to ≥1 agent in all classes but ≤2 categories including colistin (18 (link)), collected from China-Japan Friendship Hospital from January 2017 to December 2020, were used in this study. The compounds of ceftazidime, avibactam, and imipenem were purchased from MedChemExpress (MCE). These drugs were dissolved in sterile solvents to generate a stock solution, and solutions with various concentrations were further prepared in Mueller-Hinton broth. Others (aztreonam, amikacin, meropenem, piperacillin-tazobactam) were from Wenzhou KONT Biology & Technology Co., Ltd.
+ Open protocol
+ Expand
6

Antibiotics Susceptibility Profiling of P. aeruginosa

Check if the same lab product or an alternative is used in the 5 most similar protocols
β-Lactam antibiotics used were ertapenem (Merck Sharp & Dohme), imipenem (Fresenius Kabi), meropenem (Aurovitas), cefepime (Accord Healthcare), cefoxitin and ceftazidime from Laboratorios Normon (), aztreonam (Bristol-Myers Squibb), as well as doripenem, carbenicillin, piperacillin, ticarcillin, avibactam, relebactam, sulbactam, and tazobactam from MedChem Express. The β-lactam MICs were determined at least in duplicate in strain P. aeruginosa PAO1 following the Clinical and Laboratory Standards Institute (CLSI) broth microdilution method (70 ).
+ Open protocol
+ Expand
7

Antibiotic Stock Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ceftazidime and avibactam were purchased from MedChemExpress (NJ, USA). Colistin sulfate was purchased from Sigma Aldrich (Saint-Quentin-Fallavier, France). Stock solutions of antibiotics (10,240 mg/L) were prepared in sterile water, stored at −80°C, and diluted in Mueller Hinton Broth II cation adjusted (MHB) on the day of experiment to achieve the desired concentrations.
+ Open protocol
+ Expand
8

Antimicrobial Susceptibility Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
MICs were determined by the 2-fold serial dilution method in cation-adjusted Mueller-Hinton broth (CAMHB) following the Clinical and Laboratory Standards Institute (CLSI) (59 ). Avibactam (MedChemExpress, China) was used at a fixed concentration of 4 mg/L (60 (link)).
+ Open protocol
+ Expand
9

Evaluating Antimicrobial Combinations

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available meropenem (Fresenius Kabi, CA, USA; Lot: 4A2OE14) and ceftazidime (Teligent Pharma, Inc., NJ, USA; Lot: FZG001) were used for all in vivo experiments. Analytical-grade avibactam (MedChem Express, NJ, USA; Lot: 23312) was used for both in vitro MIC and in vivo experiments. MIC trays were produced using analytical-grade ceftazidime (MedChem Express, NJ, USA; Lot: 64042) and meropenem (Sigma–Aldrich, WY, USA; Lot: LRAB7853).
+ Open protocol
+ Expand
10

Antimicrobial Combination Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Imipenem (GlpBio, Montclair, CA, USA), sulbactam, avibactam, relebactam and TPEN (MedChemExpress, Monmouth Junction, NJ, USA) were used alone or in combination. Stock solutions of imipenem (2048 μg/mL), sulbactam (9132.5 μg/mL), avibactam (9132.5 μg/mL), and relebactam (9132.5 μg/mL) were prepared in sterile water. TPEN, dissolved in 100% DMSO (32 mg/mL stock solution), was diluted in sterile water to obtain the desired working concentration.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!